What Caught Our Eye: ACA Repeal Debate, the FDA’s Oncology Center of Excellence, and The Caregiver Space
| What Caught Our Eye (WCOE), Week of January 16, 2017 What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. |
Affordable Care Act
Despite recent claims, individual health insurance markets are becoming more stable, not less, according to the Center for Budget and Policy Priorities:
A "death spiral" is what happens if you repeal the #ACA — not what's happening now. New blog @CenterOnBudgethttps://t.co/yIBqBQtqjB
— Sarah Lueck (@sarahL202) January 17, 2017
The impact of the Affordable Care Act to lower the uninsured rate for working-age Latino adults is straightforward and deserves greater recognition. The uninsured rate has reduced from 43.2 percent in 2010 to 24.8 percent in 2016.
Despite large coverage gains, Latinos comprise greater share of uninsured population https://t.co/UfT1XIRJ4Y pic.twitter.com/9qAItfLbbh
— Commonwealth Fund (@commonwealthfnd) January 19, 2017
Setting the record straight: “52 million adults under 65, or 27 percent of that population, have pre-existing health conditions that would likely make them uninsurable if they applied for health coverage under medical underwriting practices that existed in most states before insurance regulation changes made by the Affordable Care Act.” – Kaiser Family Foundation
Read the Article on Kaiser Family Foundation’s Site »
Americans across the country are voicing their support for the ACA. In rallies and district events with their Members of Congress, people are sharing what the ACA means to them:
Democrats lead nationwide day of rallies in defense of Obamacare https://t.co/YVU6PkRA1O via @HuffPostPol
— Daniel Marans (@danielmarans) January 15, 2017
Here's my wrap on the Democrats' crowded "save Obamacare" rallies today https://t.co/IixdcLncrE
— Dave Weigel, Re-Animator (@daveweigel) January 15, 2017
Cancer Policy
The Food and Drug Administration announced that it established the Oncology Center of Excellence (OCE). Oncology is now the first disease area that will have coordinated clinical review of drugs, biologics and devices across the FDA’s three medical product centers. The FDA says “uniting experts to collaborate on the clinical review of oncology products will enhance the agency’s work in approving safe and effective cancer products.”
Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch. https://t.co/PMlkUrhkeY
— U.S. FDA (@US_FDA) January 19, 2017
Coping with Cancer – Caregivers
Cure Magazine highlights the Caregiver Space, an online resource that “recognizes that caregivers come in all ages and professions.”
Read “The Caregiver Space Reaches Caregivers of All Ages” on CureToday.com »
More From “What Caught Our Eye” »
Follow us on Twitter: @canceradvocacy
